About Us

Cannabis Orchards, located in Ottawa, Canada, holds an industrial hemp cultivation license since 2018. The license includes the cultivation, import, export and sale of hemp seed and flower.

We have a large bank of CBD varieties as well as two CBG varieties. For more information on procuring seeds or plant matter please contact us for more details.

Under the supervision of our certified plant breeder, we have a breeding program to produce high CBD, low THC varieties. Our internal breeding program has already led to potential candidates. Notably, our novel variety “Master Eden” is currently under testing.

Introduction of the first CBG variety and feminized seed to the Canadian hemp industry.

We hold the exclusive rights to Panakeia, the only CBG and THC-free hemp variety available worldwide. Exclusivity covers production and sale of seed, clone and plant matter in Canada. This variety contains 18% CBG and 0.00% THC. We are running trials to introduce this variety on the list of approved cultivars in Fall 2020. This will be the first CBG and the first feminized seed to be approved by Health Canada on the list of approved cultivars. Interested in purchasing seed or plant matter? Please contact us for more details!

FONDO_PANAKEIA_01.jpg

Development of a gene editing tool in Cannabis

We are undertaking a research project with the University of Ottawa on the development of a CRISPR protocol in Cannabis. We are leveraging the expertise of the molecular biology department through a public-private partnership. This is a 3-year program conducted by a post-doctoral fellow, which by the end will yield a functional CRISPR protocol capable of targeting cannabinoid content in Cannabis.

Passion to help those in need

We are motivated to provide new therapeutic options to those currently left out by the Canadian offering. With a clinical background and affiliation with the major hospitals in the Ottawa region, we can bring these hemp varieties directly to patients in need.

We are affiliated with the pediatric neurology department at our local children’s hospital with interest in pursuing a trial of the CBG, THC-free variety in children with Dravet syndrome. Many families are awaiting this trial with anticipation given its potential in reducing seizure burden without psychoactive side-effects.

patient.jpg
orchards.jpg

Industrial applications and export

Our projects have many applications, especially with the first CBG hemp variety to be introduced to the Canadian market. Given the 0.00% THC content, this will be an attractive offering to food, beverage, health supplements and cosmetics companies.

If you are outside of Canada and interested in importing our seeds, please contact us.

Meet The Team

Jamie Ghossein

CEO

B. Sc., MD candidate

ceo@cannabisorchards.ca

David Murtagh

VP, Cultivation

Hari Nair

Certified Plant Breeder

B. Sc., M. Sc., PH. D.

certification@cannabisorchards.ca

Dr. Nair is a certified plant breeder with the Canadian Seed Grower’s Association (CSGA). After joining the company in 2020, he oversees the internal breeding program, certification of new varieties with Health Canada and the CSGA as well as import/exports.

Jamie, a 4th year medical student at the University of Ottawa, leads the company strategy, especially where it pertains to R&D. Whether it be in the clinic through various partnerships with local hospitals, or with major universities for wet lab research, his direction ensures Cannabis Orchards remains on the cutting edge of therapeutic development.

David Murtagh brings years of experience as an independent breeder and hemp cultivator. His expertise in breeding led to the development of new CBD cultivars currently under testing. His background in both the agricultural and construction industry allows Cannabis Orchards to operate large scale cultivation and breeding programs with efficiency.

Jacob Varney

VP, Research

B. Sc., PH. D. candidate

research@cannabisorchards.ca

Jacob Varney is a PH. D. candidate at McGill. He leads many research projects in collaboration with the public sector. He is currently leading projects at the University of Ottawa and McGill on the development of gene editing protocols, and evaluating the interaction of endophytes with Cannabis.

Rachael Cranston

Communications Director & Media Relations

Rachael is an Environmental studies and technology Candidate at Carleton University. Her background in the environmental, technological and agricultural sectors directly bring support to every aspect of the Cannabis Orchards team. 

Cannabis Orchards Inc